| Most appropriate probiotic strain(s) | Therapeutic application | References |
| Lactobacillus plantarum 299v, Bacillus coagulans ATCC no. 31284, and Lactobacillus acidophilus L1 | Hypercholesterolemia and cardiovascular disease | [33–36] | Lactobacillus rhamnosus GG | Prevention of atopy | [37, 38] | Lactobacillus rhamnosus GG, Bifidobacterium lactis, and Lactobacillus paracasei | Eczema | [39–44] | Lactobacillus rhamnosus GG, Bifidobacterium lactis, and Lactobacillus paracasei | Food allergies | [40–49] | Lactobacillus rhamnosus, Bifidobacterium lactis, Lactobacillus johnsonii, Lactobacillus rhamnosus, and; Lactobacillus acidophilus | Lowered immunity | [50–60] | Lactobacillus rhamnosus GG, Saccharomyces cerevisiae, Lactobacillus acidophilus, and Lactobacillus plantarum 299v | Antibiotic use (during and after) | [61–72] | Lactobacillus rhamnosus GG | Nonsteroidal anti-inflammatory Drug | [73] | Lactobacillus rhamnosus GG, Saccharomyces cerevisiae | Intestinal hyperpermeability | [41, 42, 74, 75] | Lactobacillus rhamnosus GG, Lactobacillus reuteri MM53, Lactobacillus paracasei CRL431, Lactobacillus acidophilus CRL730, Lactobacillus johnsonii La1, Bifidobacterium lactis Bb12, Lactobacillus plantarum 299v, and Lactobacillus paracasei | Gastroenteritis | [40, 41, 76–85] | Lactobacillus johnsonii La1α, Lactobacillus plantarum 299v, and Lactobacillus rhamnosus GG | Giardia infection | [77, 86, 87] | Lactobacillus rhamnosus GG, Lactobacillus johnsonii La1, Lactobacillus plantarum 299v, Lactobacillus paracasei, and propionibacterium freudenreichii HA-101 and HA-102 | Intestinal dysbiosis | [64, 65, 88–93] | Lactobacillus acidophilus, Lactobacillus johnsonii La1 | Lactose intolerance | [94–98] | Lactobacillus johnsonii La1, Lactobacillus acidophilus, and Lactobacillus rhamnosus GG | Peptic ulcer disease Nonerosive gastritis | [50, 99–102] | Lactobacillus plantarum 299v, VSL no. 3β | Irritable bowel syndrome | [103–105] | Lactobacillus acidophilus NCFB 1748, VSL no. 3α | Radiation-induced diarrhoea | [106, 107] | Lactobacillus rhamnosus GG, Bifidobacterium lactis Bb12, Lactobacillus acidophilus, Saccharomyces cerevisiae, and Lactobacillus plantarum 299v | Traveller’s diarrhoea | [77, 84, 108–110] | Lactobacillus rhamnosus GG, Saccharomyces cerevisiae | Crohn’s disease | [111–114] | Escherichia coli Nissle 1917, VSL no. 3β, Lactobacillus plantarum 299 | Ulcerative colitis | [115–119] | Lactobacillus rhamnosus GG, Lactobacillus acidophilus, Lactobacillus paracasei, Lactobacillus acidophilus, and Lactobacillus delbrueckii ssp. bulgaricus strain LB-51 | Prevention of colon cancer | [120–124] | Lactobacillus rhamnosus GR-1, Lactobacillus fermentum B-54, Lactobacillus fermentum RC-14, and Lactobacillus acidophilus | Urinary tract infection | [125–132] | Lactobacillus acidophilus, Lactobacillus rhamnosus GG, Lactobacillus rhamnosus GR-1, and Lactobacillus fermentum RC-14 | Vaginal candidiasis (thrush) | [133–138] |
|
|